Toll-like receptors participate in macrophage activation and intracellular control of Leishmania 1
(Viannia) panamensis. 2
3
Running title: TLR-dependent macrophage activation by L. panamensis 4
5
Carolina Gallego1, Douglas Golenbock2, Maria Adelaida Gomez1, Nancy Saravia1* 6
7
1Centro Internacional de Entrenamiento e Investigaciones Medicas-CIDEIM, Cali- Colombia. 8
2Department of Infectious Diseases and Immunology, University of Massachusetts Medical School, 9
Worcester, Massachusetts 01605, USA. 1 0
1 1
*Corresponding Author: CIDEIM, Carrera 125 No. 19-225, Cali-Colombia. Phone: (57) 2-5552164. Fax 1 2
(57) 2-5552638. E-mail: [email protected] 1 31 4
Copyright © 2011, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.Infect. Immun. doi:10.1128/IAI.01388-10 IAI Accepts, published online ahead of print on 25 April 2011
on August 27, 2018 by guest
http://iai.asm.org/
Dow
nloaded from
Abstract 1 5
Toll-like receptors (TLRs) play a central role in macrophage activation and control of parasitic 1 6
infections. Their contribution to the outcome of Leishmania infection is just beginning to be deciphered. 1 7
We examined the interaction of Leishmania panamensis with TLRs in the activation of host 1 8
macrophages. L. panamensis infection resulted in up-regulation of TLR1, TLR2, TLR3 and TLR4 1 9
expression, and induced TNFc"secretion by human primary macrophages at comparable levels and 2 0
kinetics as specific TLR ligands. The TLR-dependence of the host cell response was substantiated by 2 1
the absence of TNFc production in MyD88/TRIF-/- murine bone marrow derived macrophages and 2 2
mouse macrophage cell lines in response to promastigotes and amastigotes. Systematic screening of 2 3
TLR-deficient macrophages revealed that TNFc production was completely abrogated in TLR4-/- 2 4
macrophages, consistent with the increased intracellular parasite survival at early time points of 2 5
infection. TNFc secretion was significantly reduced in macrophages lacking endosomal TLRs, but was 2 6
unaltered by lack of TLR2 or MD-2. Together, these findings support the participation of TLR4 and 2 7
endosomal TLRs in the activation of host macrophages by L. panamensis and in the early control of 2 8
infection. 2 93 0 on A
ugust 27, 2018 by guesthttp://iai.asm
.org/D
ownloaded from
Introduction 3 1
Protozoan parasites of the genus Leishmania are obligate intracellular pathogens that infect and 3 2
impact the lives of millions of people worldwide. Leishmania species induce a broad spectrum of 3 3
pathologies in humans, ranging from cutaneous lesions to progressive fatal visceral disease (43). 3 4
Although the determinants of pathogenesis remain unclear, the host immune response and the 3 5
infecting Leishmania species contribute to the diversity of clinical manifestations (57). 3 6
3 7
Macrophages act as the principal host cells for Leishmania, playing a central role in the development 3 8
of the immune response to these parasites via antigen presentation, secretion of microbicidal 3 9
products, and by production of inflammatory mediators (cytokines and chemokines). These early 4 0
events during host cell-parasite interaction can ultimately determine the outcome of infection (9). 4 1
Previous studies in naturally infected humans have provided evidence of differences in the innate and 4 2
acquired immune responses to L. Viannia subspecies associated with the clinical outcome of infection. 4 3
Macrophages from naturally exposed individuals presenting recurrent or chronic disease (clinical 4 4
susceptibility) were more permissive to in vitro infection than cells from individuals with subclinical 4 5
infection (clinical resistance) (9, 52). 4 6
4 7
Experimental studies have revealed that a diverse repertoire of receptors is involved in Leishmania-4 8
macrophage interactions (5, 11, 37, 39), nevertheless, the relationship between these receptors, host 4 9
cell activation and outcome of infection remains largely unknown. Toll-like receptors (TLRs) provide a 5 0
link between innate and adaptive immunity allowing recognition of a wide range of microbial products 5 1
including those of protozoan pathogens (22, 24, 35). TLR-ligand interaction initiates signal 5 2
transduction through the adaptor proteins MyD88 and/or TRIF resulting in downstream activation of 5 3
NF-mB, interferon regulatory factors and the subsequent transcription of inflammatory mediators such 5 4
on August 27, 2018 by guest
http://iai.asm.org/
Dow
nloaded from
as TNFc, type I interferons and IL-12, and the co-stimulatory molecules CD80 and CD86 in 5 5
monocytes/macrophages and dendritic cells. 5 6
5 7
Gene knockout studies in mice have revealed a critical role for TLR signaling in the immune response 5 8
against Leishmania parasites (32, 60). MyD88-/- and TLR4-/- C57BL/6 mice were more susceptible to 5 9
disease following L. major infection (18, 19, 30, 31, 42), and depletion of TLR9 impaired NK cell 6 0
activation both in murine models of visceral leishmaniasis caused by L. infantum and cutaneous 6 1
leishmaniasis produced by L. major (33, 55). A link between TLRs and microbicidal capacity was 6 2
evidenced by the requirement of TLR2 and TLR3 for intracellular killing of L. donovani in IFN-け-primed 6 3
macrophages (21). Notably, absence of TLR2 was recently shown to promote IL-12 production by DCs 6 4
during L. braziliensis infection, suggesting that this receptor may also play a negative regulatory role 6 5
(61). 6 6
6 7
Although knowledge of the nature and identity of Leishmania molecules that interact with individual 6 8
TLRs is limited, some parasite ligands and cognate TLR receptors on different cells participating in the 6 9
immune response have been described. L. major lipophosphoglycan (LPG) was shown to activate 7 0
human NK cells and murine monocytes through TLR2 (3, 18) and has been implicated in the induction 7 1
of nitric oxide (NO) production by human peripheral blood mononuclear cells (PBMCs) via TLR2 (27). 7 2
Additionally, the P8 proteoglycolipid complex (P8 PGLC) expressed by L. pifanoi has recently been 7 3
shown to promote macrophage activation through TLR4 (62), and L. major DNA to activate DCs 7 4
through TLR9 and thereby promote IFNi production by CD4+ T cells (1). The implications of these 7 5
findings and the participation of TLR signaling in the onset of the immune response during human 7 6
infections with species of the L. Viannia subgenus have yet to be determined. 7 7
7 8
on August 27, 2018 by guest
http://iai.asm.org/
Dow
nloaded from
Th1/Th2 polarization does not explain the clinical outcome in human infections with L. Viannia species, 7 9
which have a propensity to produce latent, relapsing (2) and chronic disease. Early in vitro responses 8 0
are characterized by a mixed profile of pro (IFNi TNFc) and anti-inflammatory (IL-10, IL-13) cytokine 8 1
production (20). Refractory disease presentations are often accompanied by exuberant Th1 responses 8 2
including increased TNFc production that has been implicated in pathogenesis (54). In this study we 8 3
present evidence that TLRs are involved in both activation and secretion of TNFc by human and 8 4
murine macrophages by L. panamensis and in the early control of infection. 8 58 6
on August 27, 2018 by guest
http://iai.asm.org/
Dow
nloaded from
Materials and Methods: 8 7
Parasites: L. panamensis (MHOM/CO/86/1166) promastigotes ygtg" ewnvwtgf" kp" UejpgkfgtÓu"8 8Drosophila medium (Sigma) supplemented with 20% heat-inactivated FBS (HIFBS) (Gibco) at 25°C.
8 9Luciferase and GFP-expressing promastigotes (L.p-LUC and L.p-GFP) were grown in media
9 0supplemented with 50 mg/ml of G418 (Gibco). Promastigotes were harvested during stationary phase,
9 1and opsonized for 1 h at 34°C in RPMI 1640 (Gibco) supplemented with 10% heat inactivated human
9 2AB serum when indicated. Live intracellular amastigotes were obtained by infection of differentiated
9 3adherent U937 cells with opsonized promastigotes (50:1 parasite-to-cell ratio) for 5 days at 34°C and
9 45% CO2. After infection, cells were lysed by passage through a 27G needle and amastigotes were
9 5recovered by centrifugation over a Percoll density gradient (Amersham Biosciences).
9 6
9 7Macrophages: Human promonocytic U-937 cells were cultured as previously described (52). Cell
9 8differentiation was induced by phorbol 12-myristate 13-acetate (PMA) stimulation (100 ng/ml) (Sigma)
9 94 days prior to infection. Immortalized macrophage cell lines generated from wild type (WT),
1 0 0MyD88/TRIF-/-, MyD88-/-, TRIF-/-, TLR2-/-, TLR4-/- and UNC93b mutant C57BL/6 mice were cultured as
1 0 1previously described (23). Clonal lines were tested for the induction of TNFc and IL-6 in response to a
1 0 2panel of TLR ligands, including synthetic lipopeptide, polyinosinic-polycytidylic acid (Poly I:C) , LPS,
1 0 3resiquimod and CpG DNA. In all cases, the predicted responses, based on the known responses of
1 0 4native bone marrow-derived macrophages, were observed (e.g., the TLR4 knockout responded to all
1 0 5TLR ligands except LPS). Cells were maintained in DMEM (Cellgro) supplemented with 10% HIFBS
1 0 6and 10"og of ciprofloxacin/ml (Bayer). Cells were plated and stimulated with TLR ligands or infected
1 0 7with L. panamensis parasites as described in the text.
1 0 8
1 0 9
on August 27, 2018 by guest
http://iai.asm.org/
Dow
nloaded from
All mice were housed and bred in pathogen-free conditions. Bone marrow was harvested from mice as 1 1 0
previously described (62) in accordance with the guidelines set forth by the University of 1 1 1
Massachusetts Medical School and approved by its Institutional Animal Care and Use Committee. 1 1 2
BMM precursors from WT (C57BL/6), MD-2-/-, MyD88/TRIF-/-, MyD88-/-, TRIF-/-, or TLR4-/- mice were 1 1 3
differentiated in culture for 9-10 days in the presence of conditioned medium (DMEM supplemented 1 1 4
with 20% L929 cell culture supernatant, 10% HIFBS, and 10 µg/ml ciprofloxacin) prior to use. 1 1 5
1 1 6
Isolation and culture of human monocyte-derived macrophages: Sixty ml of peripheral blood was 1 1 7
obtained from healthy adult volunteers in accordance with the protocol and informed consent forms 1 1 8
approved by the Institutional Review Board of CIDEIM. PBMCs were obtained from peripheral blood 1 1 9
using Ficoll-hypaque 1077 (Sigma) density gradient centrifugation. Monocytes were allowed to 1 2 0
differentiate to macrophages by culture for 7 days at 37°C and 5% CO2 in complete RPMI (Sigma) 1 2 1
following adherence to plates coated with 2% sterile endotoxin-free gelatin and autologous human 1 2 2
serum. All plasticware, glassware and water used for cell culture were endotoxin-free. 1 2 3
1 2 4
L. panamensis infection and TLR-ligand stimulation: Primary human macrophages were 1 2 5
stimulated for 8 h with LPS (1"og/ml), zymozan (25 og/ml), Pam2CSK4 (10"og/ml), Poly I:C (20 1 2 6
og/ml), or CpG ODN 2216 (5 oM) (Invivogen), or infected with opsonized L. panamensis 1 2 7
promastigotes at a 5:1 parasites-to-cell ratio. Infection was allowed to proceed for 1 h in FBS-free 1 2 8
medium at 34°C and 5% CO2. Extracellular parasites were removed by washing with D-PBS and cells 1 2 9
were incubated for 8 h at 34°C and 5% CO2. 1 3 0
1 3 1
Mouse macrophage cell lines and BMMs were infected with L. panamensis promastigotes and 1 3 2
amastigotes at 50:1 to 200:1 parasites-to-cell ratio for 1 h, washed with D-PBS and incubated at 34°C 1 3 3
on August 27, 2018 by guest
http://iai.asm.org/
Dow
nloaded from
and 5% CO2. These parasites to cell ratios using serum-opsonized as well as non-opsonized parasites 1 3 4
were chosen to optimize infection and read out based on prior dose response experiments. 1 3 5
Supernatants were collected and TNFc was evaluated 24 h post-infection. Stimulations with 1 3 6
Pam2CSK4 (4 oM), Poly I:C (100 og/ml), CpG (5 oM) and LPS (1 og/ml) or with the non-TLR ligand 1 3 7
Sendai virus (500 U/ml) were used as positive and negative controls, as indicated. The TLR4/MD-2 1 3 8
antagonist Eritoran (10 µg/ml) (Eisai Research Institute) was used to discriminate activation 1 3 9
attributable to endotoxin contamination. Infection was evaluated in Giemsa stained cells by 1 4 0
microscopy. 1 4 1
1 4 2
WT and TLR4-/- macrophages were seeded on glass cover slips and infected with L. p-GFP 1 4 3
promastigotes at 20:1 parasite to cell ratio to visualize parasite internalization by confocal microscopy 1 4 4
(Leica SP2 AOBS). Cell membranes were stained with CellMask Deep Red stain (Invitrogen). 1 4 5
1 4 6
FACS analysis: Human macrophages were harvested and incubated with 10"og of non-immune 1 4 7
human IgG (BD Biosciences) to block nonspecific binding to FciR and then incubated with PE-labeled 1 4 8
monoclonal anti-TLR1 (clone GD2.F4), anti-TLR2 (clone TL2.1) or anti-TLR4 (clone HTA125) 1 4 9
antibodies. FITC-labeled anti-CD14 was used as monocyte population marker. For intracellular 1 5 0
staining, cells were fixed and permeabilized with Cytofix/Cytoperm solution, washed with PermWash 1 5 1
solution (BD Biosciences), and incubated with monoclonal anti-TLR3 (clone TLR3.7) or anti-TLR9 1 5 2
(eB72-1665). Cells were fixed with 2% para-formaldehyde. PE- IgG1m, PE-mouse IgG2a and PE-1 5 3
mouse IgG1 were used as isotype controls. All antibodies were purchased from e-Biosciences. Cells 1 5 4
were evaluated using a FACSCalibur cytometer (BD Biosciences) and analyzed with the WinMDI 2.9 1 5 5
software (Scripps Research Institute). 1 5 6
1 5 7
on August 27, 2018 by guest
http://iai.asm.org/
Dow
nloaded from
Quantification of TNF : Human TNFc ELISA was performed using antibodies from BD Pharmingen 1 5 8
following the manufacturer´s instructions. Mouse TNFc was quantified by ELISA with the TNFc 1 5 9
FwqUgv" GNKUC" mkv" *T(F+" hqnnqykpi" vjg" ocpwhcevwtgtÓu" kpuvtwevkqpu0" Cnn" samples were evaluated in 1 6 0
duplicate. 1 6 1
1 6 2
Luciferase assay: L. p-Luc promastigotes were used to infect macrophages for 1 h. Non-internalized 1 6 3
parasites were removed by washing and macrophages were further incubated for 4, 16, 24 and 36 h. 1 6 4
Cells were lysed and analyzed using the dual luciferase reporter assay system (Promega) according 1 6 5
to the ocpwhcevwtgtÓu"kpuvtwevkqpu. 1 6 6
1 6 7
Statistical analysis: Fkhhgtgpegu"kp"rcktgf"itqwru"ygtg"gxcnwcvgf"d{"UvwfgpvÓu" t test or the Wilcoxon 1 6 8
rank test. For group comparisons the Kruskal-Wallis test was used ykvj"FwppÓu"cflwuvogpv0"Cpcn{ugu"1 6 9were performed with the GraphPad Prism 5 software (GraphPad Inc., San Diego, CA) and p values of
1 7 0<0.05 were considered significant.
1 7 1
1 7 2Results
1 7 3L. panamensis promastigotes induce TNF production and increased expression of TLR1,
1 7 4TLR2, TLR3 and TLR4 by human macrophages.
1 7 5TNFc production was used as an early readout of TLR-dependent macrophage activation [reviewed in
1 7 6(59)]. TNFc secretion following exposure to live promastigotes peaked at 8 h decreasing by 24 hours
1 7 7(Fig. 1A). The kinetics and level of production of TNFc in response to L. panamensis and specific TLR
1 7 8ligands by human macrophages were comparable (Fig. 1B), consistent with TLR-dependent activation
1 7 9of this host cell by L. panamensis. Stimulation of human macrophages with TLR ligands induced
1 8 0increased expression of the corresponding TLRs (Figure 2 lower panel and data not shown). Similarly,
1 8 1
on August 27, 2018 by guest
http://iai.asm.org/
Dow
nloaded from
co-culture with live L. panamensis significantly increased the cell surface expression of TLR1, TLR2 1 8 2
and TLR4 and the intracellular expression of TLR3, but not TLR9, compared to unexposed 1 8 3
macrophages (Fig. 2). 1 8 4
1 8 5
L. panamensis promastigotes and amastigotes activate TNF production through TLRs. 1 8 6
Based on the results supporting the involvement of TLRs in the L. panamensis-human macrophage 1 8 7
interaction, we investigated the participation of specific TLRs and adaptor molecules in cell activation. 1 8 8
Human HEK293 cells stably transfected with individual human TLRs and a NF-mB-luciferase reporter 1 8 9
construct were used as a surrogate model of infection and cell activation. However, HEK293 cells 1 9 0
deteriorated during co-culture with L. panamensis promastigotes, leading us to examine specific TLR 1 9 1
activation in C57BL/6-derived macrophage cell lines. 1 9 2
1 9 3
TNFc production was induced in a dose-dependent manner in the WT C57BL/6 macrophage cell line 1 9 4
by both promastigotes and amastigotes of L. panamensis over a wide dose range of parasites (Fig. 1 9 5
3A). In contrast, neither parasite stage induced TNFc production in the MyD88/TRIF-/- double 1 9 6
knockout macrophage cell line in which all TLRs are non-functional (Fig. 3B), supporting the 1 9 7
involvement of TLR-dependent signaling during macrophage activation by L. panamensis. TNFc 1 9 8
secretion induced by opsonized and non-opsonized parasites was indistinguishable (Fig. 3A and data 1 9 9
not shown), ruling out cell activation attributable to interactions with serum opsonins in this 2 0 0
experimental system. 2 0 1
2 0 2
MD-2, a small protein that together with TLR4 forms the LPS-signaling complex is an absolute 2 0 3
requirement for cells to respond to LPS (56) . Eritoran (previously known as B1287) binds to the lipid A 2 0 4
binding site of MD-2, and is a potent inhibitor of LPS mediated activation. Eritoran did not impair 2 0 5
on August 27, 2018 by guest
http://iai.asm.org/
Dow
nloaded from
induction of TNFc by L. panamensis, whereas induction by LPS was blocked (Fig. 3A), thereby 2 0 6
establishing that the macrophage response to L. panamensis could not be attributable to LPS 2 0 7
contamination. 2 0 8
2 0 9
To dissect the TLR signaling pathway activated by L. panamensis in macrophages, we examined the 2 1 0
response of MyD88-/- and TRIF-/- single knockout macrophages to opsonized and non-opsonized 2 1 1
parasites. In contrast to the complete abrogation of TNFc secretion in MyD88/TRIF-/- double knockout 2 1 2
macrophages co-cultured with L. panamensis, specific ablation of either MyD88 or TRIF alone, did not 2 1 3
significantly alter TNFc"production (Fig. 4A-B). Similar results were obtained with opsonized and non-2 1 4
opsonized parasites (Fig. 4A-B). These results indicate that both MyD88 and TRIF are required to fully 2 1 5
induce TNFc production by L. panamensis in this experimental system. 2 1 6
2 1 7
Endosomal TLRs participate in macrophage activation by L. panamensis infection. 2 1 8
UNC93b is an endoplasmic reticulum (ER) membrane protein required for signaling through 2 1 9
endolysosomal TLRs (10) by controlling the trafficking of TLRs 3, 7, 8 and 9 from the ER to the 2 2 0
endolysosomal compartment. Hence, UNC93b mutant cells do not respond to the corresponding TLR 2 2 1
ligands (28). To investigate the role of the endolysosomal TLRs during L. panamensis infection, we 2 2 2
examined the activation of macrophages expressing a non-functional form of UNC93b (58). Induction 2 2 3
of TNFc production by both L. panamensis promastigotes and amastigotes was significantly reduced, 2 2 4
though not completely abrogated, when compared to WT cells""*Fig. 5), suggesting that signaling 2 2 5
through the endolysosomal TLRs also contributes to macrophage activation during L. panamensis 2 2 6
infection. 2 2 7
2 2 8
TLR4 mediates L. panamensis recognition by macrophages 2 2 9
on August 27, 2018 by guest
http://iai.asm.org/
Dow
nloaded from
We next examined the induction of TNFc production in TLR2-/- and TLR4-/- macrophage cell lines. As 2 3 0
shown in Fig. 6A, no significant change in TNFc secretion was observed in TLR2-/- macrophages 2 3 1
compared to WT cells, suggesting that TLR2 is not critical for L. panamensis-mediated macrophage 2 3 2
activation. In contrast, TNFc production was abrogated in TLR4-/- macrophages following infection 2 3 3
with either opsonized or non-opsonized promastigotes or amastigotes (Fig. 6C). These results indicate 2 3 4
that TLR4, but not TLR2, has an important role in the induction of pro-inflammatory cytokine secretion 2 3 5
by macrophages during infection by L. panamensis. 2 3 6
2 3 7
BMMs from MD-2 deficient C57BL/6 mice were used to confirm the specificity of L. panamensis-2 3 8
mediated macrophage activation via TLR4, and unequivocally rule out activation attributable to 2 3 9
endotoxin contamination. Both promastigotes and amastigotes induced similar and significant levels of 2 4 0
TNFc"production in MD-2-/- and WT BMMs, confirming that macrophage activation through TLR4 was 2 4 1
induced by L. panamensis infection (Fig. 6C), and not LPS contamination. 2 4 2
2 4 3
TLR4 is required for induction of leishmanicidal activity of macrophages. 2 4 4
Evaluation of intracellular killing of L. panamensis over the time course of infection from 4 to 48 h 2 4 5
showed that by 16 h post-infection intracellular parasite survival in WT macrophages was reduced by 2 4 6
up to 70%. In contrast, L. panamensis not only survived but replicated during the first 16 h in TLR4-/- 2 4 7
macrophages (Fig. 7). The parasite burden at the initial time point (4 h) of infection was comparable 2 4 8
between WT and TLR4-/- cells (165380 and 143500 RLU, respectively), confirming similar infection 2 4 9
rates in both cell lines. Confocal microscopy of WT and TLR4-/- cells infected with GFP-transfected 2 5 0
parasites corroborated equivalent parasite infectivity and internalization (Fig.7B). By 24 h post-2 5 1
infection, parasite survival decreased in TLR4-/- macrophages to levels comparable to WT host cells 2 5 2
supporting the participation of TLR4 during the very early stages of parasite-macrophage interaction. 2 5 3
on August 27, 2018 by guest
http://iai.asm.org/
Dow
nloaded from
2 5 4
Other MyD88-dependent receptors may participate in macrophage activation in response to L. 2 5 5
panamensis. 2 5 6
To extend the findings obtained in macrophage cell lines to an infection approximating natural host cell 2 5 7
interaction, we systematically evaluated the response of primary C57BL/6 WT BMMs, and knockout 2 5 8
BMMs lacking specific TLRs and adaptor molecules. As observed in murine cell lines, TNFc 2 5 9
production was significantly reduced in TLR4-/- and MyD88/TRIF-/- BMMs exposed to L. panamensis 2 6 0
(Fig. 8A and B). However, in contrast to the results in knockout cell lines in which deficiency of either 2 6 1
MyD88 or TRIF alone did not significantly alter TNFc production, MyD88-/- BMMs co-cultured with L. 2 6 2
panamensis produced significantly lower TNFc upon exposure to L. panamensis compared with WT 2 6 3
cells (Fig. 8C and D). Deficiency of TRIF did not significantly alter TNF production by BMMs. In 2 6 4
addition, a striking and consistently greater production of TNFc production was induced in BMMs by 2 6 5
opsonized versus non-opsonized parasites. This increased TNFc response coincided with the higher 2 6 6
percentage of infection observed in BMMs exposed to opsonized parasites (data not shown). The 2 6 7
enhancement of TNFc secretion by opsonized parasites in this experimental model is consistent with 2 6 8
the participation of receptors other than TLR4 in L. panamensis-mediated BMM activation. 2 6 92 7 0 on A
ugust 27, 2018 by guesthttp://iai.asm
.org/D
ownloaded from
Discussion 2 7 1
2 7 2
Macrophages are central to host defense, from pathogen detection and clearance to the induction of 2 7 3
adaptive immune responses (40). The outcome of Leishmania infection is largely determined by the 2 7 4
ability of macrophages to recognize and respond to the parasite (4, 6, 8, 9, 37, 41, 52). Although 2 7 5
several macrophage receptors evidently participate in the Leishmania-host cell interaction (5, 11, 37, 2 7 6
39, 41), their role in the modulation of host immune responses and clinical outcomes of infection is not 2 7 7
yet clear. This study sought to determine the participation of TLRs in L. panamensis-mediated 2 7 8
modulation of host cell responses. 2 7 9
2 8 0
Contrary to the negative regulation of host cell functions reported in L. donovani infection, strong pro 2 8 1
and anti-inflammatory cytokine production is a hallmark of infection by parasites of the L. Viannia 2 8 2
subgenus (43). TNFc is thought to play an important role during L. braziliensis infection, contributing 2 8 3
to disease control in the early stages and exacerbation of disease at later stages of infection (2, 16, 2 8 4
50, 53). Mucosal leishmaniasis is characterized by high levels of TNFc production, and genetic 2 8 5
polymorphisms in the promoter region of TNF genes have been linked to susceptibility to mucosal 2 8 6
disease (4, 13). The early induction of TNFc production in isolated human macrophages by L. 2 8 7
panamensis promastigotes, provided initial evidence of putative receptor-mediated cell activation. 2 8 8
Concurrence of the kinetics of TNFc production induced by L. panamensis and by specific TLR 2 8 9
ligands, and the up-regulation of TLR1, TLR2, TLR3 and TLR4 expression in human macrophages 2 9 0
exposed to L panamensis promastigotes (Fig. 2) further supported the possibility of TLR mediated 2 9 1
activation and TNFc production. 2 9 2
2 9 3
on August 27, 2018 by guest
http://iai.asm.org/
Dow
nloaded from
Deletion of both MyD88/TRIF, essential adaptor molecules in signal transduction initiated by TLR 2 9 4
engagement, resulted in the abrogation of TNFc secretion by mouse macrophages. This finding 2 9 5
demonstrated that host cell activation by both L. panamensis amastigotes and promastigotes is TLR-2 9 6
dependent. Although differences in macrophage responses to promastigotes and amastigotes of other 2 9 7
Leishmania species are well documented (29), including decreased superoxide and increased anti-2 9 8
inflammatory cytokines in response to infection with amastigotes (15, 46, 47), the induction of TNFc 2 9 9
by these life stages was indistinguishable in this experimental infection model. This finding suggests 3 0 0
that L. panamensis TLR ligand(s) are similarly expressed by both amastigotes and promastigotes, or 3 0 1
alternatively, that different stage-specific molecules can redundantly stimulate TLR signaling. 3 0 2
3 0 3
The most compelling evidence to date for the participation of TLRs in Leishmania infection and 3 0 4
pathogenesis is the enhanced susceptibility of MyD88-deficient mice to L. major, accompanied by 3 0 5
impaired pro-inflammatory cytokine synthesis and diminished Th1 T cell activation (19, 42). However, 3 0 6
this enhanced susceptibility to L major has not been attributed to any specific TLR family member. 3 0 7
Using MyD88-/- and TRIF-/- macrophage cell lines we found that absence of either of these adaptor 3 0 8
molecules did not significantly alter TNFc"production induced by L. panamensis promastigotes, or 3 0 9
amastigotes. These findings suggest that signaling in response to L panamensis occurs through both 3 1 0
pathways, and in the absence of either, the other can compensate, sustaining TLR signaling and host 3 1 1
cell activation. 3 1 2
3 1 3
Studies addressing the role of MyD88 in macrophage activation during infection with the closely 3 1 4
related species L. braziliensis have yielded conflicting results. Recently, Carvalho et al. showed that 3 1 5
TNFc secretion by DCs during L. braziliensis infection was MyD88-independent (14). In contrast, 3 1 6
Vargas and collaborators reported that L. braziliensis-infected MyD88-/- DCs exhibited reduced 3 1 7
on August 27, 2018 by guest
http://iai.asm.org/
Dow
nloaded from
activation and decreased production of IL-12p40, which is fundamental to the generation of protective 3 1 8
immunity (61). Notwithstanding differences in experimental models, these results raise the issue of 3 1 9
intra as well as inter-species variation in TLR mediated activation. Despite the similarity of L. 3 2 0
braziliensis and L. panamensis as related members of the Viannia subgenus, parasites of these 3 2 1
species may trigger different mechanisms of cell activation. Therefore, generalization of results 3 2 2
obtained with one species may not be appropriate or accurately portray the interaction with other 3 2 3
Leishmania species, even within the same taxonomic grouping. 3 2 4
3 2 5
The partial abrogation of TNFc production in UNC93b deficient mutant macrophages in response to L. 3 2 6
panamensis infection supports the involvement of signaling through endolysosomal TLRs, and 3 2 7
concurs with evidence of endolysosomal TLR participation in the immune response to other 3 2 8
Leishmania species. TLR3 has been implicated in the recognition of L. donovani by IFNi-primed 3 2 9
macrophages (21), and TLR9 in DC-mediated NK cell activation and T cell responses following L. 3 3 0
infantum and L. major infection, respectively (33, 55). L. major DNA has been shown to promote IFNi 3 3 1production by CD4+ T cells through TLR 9 dependent activation of DCs (1). The potential therapeutic
3 3 2applicability of activation through endolysosomal TLRs has been demonstrated by the enhanced
3 3 3resolution of experimental L. donovani infection and human cutaneous leishmaniasis (12, 36) using
3 3 4the TLR 7/8 ligand imiquimod. Although our results support the participation of endolysosomal TLR
3 3 5signaling during L. panamensis infection the specific TLR(s) involved remain to be identified. Since all
3 3 6of the endolysosomal TLRs recognize nucleotide ligands, it is reasonable to hypothesize that
3 3 7Leishmania nucleic acids are involved in the innate immune response to infection.
3 3 8
3 3 9TLR2 has been reported to be involved in the host response to L. major and L donovani through the
3 4 0recognition of LPG, which activates human NK cells and murine macrophages through this receptor
3 4 1
on August 27, 2018 by guest
http://iai.asm.org/
Dow
nloaded from
(3, 18). Inhibition of TLR2 expression impaired NO production and TNFc secretion in IFNi-primed 3 4 2
mouse macrophages (21). Our results showed that, although L. panamensis induced increased TLR2 3 4 3
expression in human macrophages, absence of TLR2 in murine macrophage lines did not affect TNFc 3 4 4
production by promastigotes or amastigotes. This finding and the observation that parasites of the 3 4 5
Viannia subgenus express 10-fold less LPG than L. donovani (44), suggest that TLR2 may not be a 3 4 6
crucial determinant of the host cell response to L. panamensis. 3 4 7
3 4 8
The importance of TLR4 signaling in Leishmania infection is supported by the increased susceptibility 3 4 9
of TLR4-/- C57BL/6 and BALB/c respectively, to L. major and L pifanoi infection (30, 31). Furthermore, 3 5 0
L. pifanoi P8 PGLC, has been shown to induce TLR4-dependent macrophage cytokine and chemokine 3 5 1
production (62). Our data provide evidence that TLR4 is also important during the early L. 3 5 2
panamensis-macrophage interaction since reduced TNFc production and increased parasite survival 3 5 3
occurred in TLR4-/- infected mouse macrophages. The results were further supported by ruling out any 3 5 4
possibility of attributing activation to endotoxin contamination using MD-2-/- BMMs (Fig. 6C), thereby 3 5 5
providing unequivocal evidence that the TLR4 response was induced by L panamensis parasites. The 3 5 6
significant decrease in TNFc production in MyD88-/- BMMs, is consistent with the ability of TLR4 to 3 5 7
signal preferentially through MyD88 (25) as previously reported for other Leishmania species (17, 18, 3 5 8
42). These findings encourage identification of the nature of the ligand(s) involved in the TLR4-3 5 9
dependent response to L. panamensis. 3 6 0
3 6 1
A noteworthy difference between the activation of immortalized macrophage cell lines versus BMMs 3 6 2
was the enhanced TNFc secretion induced by opsonized parasites in BMMs. Under physiological 3 6 3
conditions, opsonins (including complement components and antibodies) rapidly interact with the cell 3 6 4
surface of promastigotes after their inoculation into the dermis of mammals or with amastigotes when 3 6 5
on August 27, 2018 by guest
http://iai.asm.org/
Dow
nloaded from
they leave their host cells (48). Opsonization promotes the uptake of parasites by phagocytic cells (63) 3 6 6
principally mediated by Fc and complement receptors, and also mediates the release of anti-3 6 7
inflammatory cytokines (26, 38, 39). Opsonization could also favor the synergistic recognition of 3 6 8
Leishmania parasites through various different receptors (7), eliciting enhanced or diminished 3 6 9
activating signals and cytokine production (49, 51). Although not evaluated in this study, differences in 3 7 0
expression levels of TLRs or other receptors that interact with Leishmania, the maturation stage (34) 3 7 1
and the functional integrity of permanent cell lines (45) may account for differences observed in the 3 7 2
response elicited in primary macrophages and macrophage cell lines in response to parasite 3 7 3
opsonization. Interpretation and extrapolation of results obtained with cell lines to primary cell 3 7 4
populations or either of these to whole organisms and vice versa merit consideration of the 3 7 5
characteristics and limitations of each model system. Although the generalization of observations in 3 7 6
these models to natural human infection is uncertain, exploitation of these experimental models 3 7 7
allowed the discrimination of TLRs involved in the L. panamensis-macrophage interaction. Findings in 3 7 8
human macrophages also support the involvement of multiple TLRs, including TLR4, in the host cell 3 7 9
interaction with L. panamensis. 3 8 0
3 8 1
In conclusion, our results demonstrate TLR4-mediated macrophage activation and cooperation with 3 8 2
other TLRs during infection by L panamensis. The findings provide insight into the mechanism of 3 8 3
parasite recognition and evidence that early induction of TNFc production mediated by ligation of 3 8 4
TLRs contribute to control of infection. Understanding of the participation of TLRs in the outcome of 3 8 5
Leishmania infection may allow the exploitation of these receptors or their ligands in the development 3 8 6
of co-adjuvant immunotherapy. 3 8 7
3 8 8
Acknowledgements 3 8 9
on August 27, 2018 by guest
http://iai.asm.org/
Dow
nloaded from
We thank Liliana Valderrama and Diane McMahon-Pratt for their insights during the development of 3 9 0
this investigation and critical review of this manuscript. The support of Mauricio Perez with statistical 3 9 1
analysis, Adriana Navas with cytometric analysis, Anna Cerny with animal husbandry and the 3 9 2
technical assistance of Kristen Halmen, are gratefully acknowledged. This work was supported by a 3 9 3
NIH/NIAID grant (AI065866), NIH/ John E. Fogarty International Center GID training grant 3 9 4
(TW006589), COLCIENCIAS doctoral training fellowship (041-2005) to C.G. and NIH/NIAID grant 3 9 5
(AI079293) to D.G. 3 9 6
The authors have no financial or other conflict of interest 3 9 7
References 3 9 8
1. Abou Fakher, F. H., N. Rachinel, M. Klimczak, J. Louis, and N. Doyen. 2009. TLR9-3 9 9
dependent activation of dendritic cells by DNA from Leishmania major favors Th1 cell 4 0 0
development and the resolution of lesions. J Immunol 182:1386-1396. 4 0 1
2. Bacellar, O., H. Lessa, A. Schriefer, P. Machado, A. Ribeiro de Jesus, W. O. Dutra, K. J. 4 0 2
Gollob, and E. M. Carvalho. 2002. Up-regulation of Th1-type responses in mucosal 4 0 3
leishmaniasis patients. Infect Immun 70:6734-6740. 4 0 4
3. Becker, I., N. Salaiza, M. Aguirre, J. Delgado, N. Carrillo-Carrasco, L. G. Kobeh, A. Ruiz, 4 0 5
R. Cervantes, A. P. Torres, N. Cabrera, A. Gonzalez, C. Maldonado, and A. Isibasi. 2003. 4 0 6
Leishmania lipophosphoglycan (LPG) activates NK cells through toll-like receptor-2. Mol 4 0 7
Biochem Parasitol 130:65-74. 4 0 8
4. Blackwell, J. M. 1996. Genetic susceptibility to leishmanial infections: studies in mice and 4 0 9
man. Parasitology 112 Suppl:S67-74. 4 1 0
5. Blackwell, J. M., R. A. Ezekowitz, M. B. Roberts, J. Y. Channon, R. B. Sim, and S. 4 1 1
Gordon. 1985. Macrophage complement and lectin-like receptors bind Leishmania in the 4 1 2
absence of serum. J Exp Med 162:324-331. 4 1 3
on August 27, 2018 by guest
http://iai.asm.org/
Dow
nloaded from
6. Bogdan, C., A. Gessner, W. Solbach, and M. Rollinghoff. 1996. Invasion, control and 4 1 4
persistence of Leishmania parasites. Curr Opin Immunol 8:517-525. 4 1 5
7. Bosetto, M. C., and S. Giorgio. 2007. Leishmania amazonensis: multiple receptor-ligand 4 1 6
interactions are involved in amastigote infection of human dendritic cells. Exp Parasitol 4 1 7
116:306-310. 4 1 8
8. Bosque, F., G. Milon, L. Valderrama, and N. G. Saravia. 1998. Permissiveness of human 4 1 9
monocytes and monocyte-derived macrophages to infection by promastigotes of Leishmania 4 2 0
(Viannia) panamensis. J Parasitol 84:1250-1256. 4 2 1
9. Bosque, F., N. G. Saravia, L. Valderrama, and G. Milon. 2000. Distinct innate and acquired 4 2 2
immune responses to Leishmania in putative susceptible and resistant human populations 4 2 3
endemically exposed to L. (Viannia) panamensis infection. Scand J Immunol 51:533-541. 4 2 4
10. Brinkmann, M. M., E. Spooner, K. Hoebe, B. Beutler, H. L. Ploegh, and Y. M. Kim. 2007. 4 2 5
The interaction between the ER membrane protein UNC93B and TLR3, 7, and 9 is crucial for 4 2 6
TLR signaling. J Cell Biol 177:265-275. 4 2 7
11. Brittingham, A., and D. M. Mosser. 1996. Exploitation of the complement system by 4 2 8
Leishmania promastigotes. Parasitol Today 12:444-447. 4 2 9
12. Buates, S., and G. Matlashewski. 1999. Treatment of experimental leishmaniasis with the 4 3 0
immunomodulators imiquimod and S-28463: efficacy and mode of action. J Infect Dis 4 3 1
179:1485-1494. 4 3 2
13. Cabrera, M., M. A. Shaw, C. Sharples, H. Williams, M. Castes, J. Convit, and J. M. 4 3 3
Blackwell. 1995. Polymorphism in tumor necrosis factor genes associated with 4 3 4
mucocutaneous leishmaniasis. J Exp Med 182:1259-1264. 4 3 5
14. Carvalho, L. P., E. J. Pearce, and P. Scott. 2008. Functional dichotomy of dendritic cells 4 3 6
following interaction with Leishmania braziliensis: infected cells produce high levels of TNF-4 3 7
on August 27, 2018 by guest
http://iai.asm.org/
Dow
nloaded from
alpha, whereas bystander dendritic cells are activated to promote T cell responses. J Immunol 4 3 8
181:6473-6480. 4 3 9
15. Channon, J. Y., M. B. Roberts, and J. M. Blackwell. 1984. A study of the differential 4 4 0
respiratory burst activity elicited by promastigotes and amastigotes of Leishmania donovani in 4 4 1
murine resident peritoneal macrophages. Immunology 53:345-355. 4 4 2
16. Da-Cruz, A. M., M. P. de Oliveira, P. M. De Luca, S. C. Mendonca, and S. G. Coutinho. 4 4 3
1996. Tumor necrosis factor-alpha in human american tegumentary leishmaniasis. Mem Inst 4 4 4
Oswaldo Cruz 91:225-229. 4 4 5
17. De Trez, C., M. Brait, O. Leo, T. Aebischer, F. A. Torrentera, Y. Carlier, and E. Muraille. 4 4 6
2004. Myd88-dependent in vivo maturation of splenic dendritic cells induced by Leishmania 4 4 7
donovani and other Leishmania species. Infect Immun 72:824-832. 4 4 8
18. de Veer, M. J., J. M. Curtis, T. M. Baldwin, J. A. DiDonato, A. Sexton, M. J. McConville, E. 4 4 9
Handman, and L. Schofield. 2003. MyD88 is essential for clearance of Leishmania major: 4 5 0
possible role for lipophosphoglycan and Toll-like receptor 2 signaling. Eur J Immunol 33:2822-4 5 1
2831. 4 5 2
19. Debus, A., J. Glasner, M. Rollinghoff, and A. Gessner. 2003. High levels of susceptibility 4 5 3
and T helper 2 response in MyD88-deficient mice infected with Leishmania major are 4 5 4
interleukin-4 dependent. Infect Immun 71:7215-7218. 4 5 5
20. Diaz, Y. R., R. Rojas, L. Valderrama, and N. G. Saravia. T-bet, GATA-3, and Foxp3 4 5 6
expression and Th1/Th2 cytokine production in the clinical outcome of human infection with 4 5 7
Leishmania (Viannia) species. J Infect Dis 202:406-415. 4 5 8
21. Flandin, J. F., F. Chano, and A. Descoteaux. 2006. RNA interference reveals a role for 4 5 9
TLR2 and TLR3 in the recognition of Leishmania donovani promastigotes by interferon-4 6 0
gamma-primed macrophages. Eur J Immunol 36:411-420. 4 6 1
on August 27, 2018 by guest
http://iai.asm.org/
Dow
nloaded from
22. Gazzinelli, R. T., and E. Y. Denkers. 2006. Protozoan encounters with Toll-like receptor 4 6 2
signalling pathways: implications for host parasitism. Nat Rev Immunol 6:895-906. 4 6 3
23. Halle, A., V. Hornung, G. C. Petzold, C. R. Stewart, B. G. Monks, T. Reinheckel, K. A. 4 6 4
Fitzgerald, E. Latz, K. J. Moore, and D. T. Golenbock. 2008. The NALP3 inflammasome is 4 6 5
involved in the innate immune response to amyloid-beta. Nat Immunol 9:857-865. 4 6 6
24. Janeway, C. A., Jr., and R. Medzhitov. 2002. Innate immune recognition. Annu Rev 4 6 7
Immunol 20:197-216. 4 6 8
25. Kagan, J. C., T. Su, T. Horng, A. Chow, S. Akira, and R. Medzhitov. 2008. TRAM couples 4 6 9
endocytosis of Toll-like receptor 4 to the induction of interferon-beta. Nat Immunol 9:361-368. 4 7 0
26. Kane, M. M., and D. M. Mosser. 2001. The role of IL-10 in promoting disease progression in 4 7 1
leishmaniasis. J Immunol 166:1141-1147. 4 7 2
27. Kavoosi, G., S. K. Ardestani, and A. Kariminia. 2009. The involvement of TLR2 in cytokine 4 7 3
and reactive oxygen species (ROS) production by PBMCs in response to Leishmania major 4 7 4
phosphoglycans (PGs). Parasitology 136:1193-1199. 4 7 5
28. Kim, Y. M., M. M. Brinkmann, M. E. Paquet, and H. L. Ploegh. 2008. UNC93B1 delivers 4 7 6
nucleotide-sensing toll-like receptors to endolysosomes. Nature 452:234-238. 4 7 7
29. Kima, P. E. 2007. The amastigote forms of Leishmania are experts at exploiting host cell 4 7 8
processes to establish infection and persist. Int J Parasitol 37:1087-1096. 4 7 9
30. Kropf, P., M. A. Freudenberg, M. Modolell, H. P. Price, S. Herath, S. Antoniazi, C. 4 8 0
Galanos, D. F. Smith, and I. Muller. 2004. Toll-like receptor 4 contributes to efficient control 4 8 1
of infection with the protozoan parasite Leishmania major. Infect Immun 72:1920-1928. 4 8 2
31. Kropf, P., N. Freudenberg, C. Kalis, M. Modolell, S. Herath, C. Galanos, M. Freudenberg, 4 8 3
and I. Muller. 2004. Infection of C57BL/10ScCr and C57BL/10ScNCr mice with Leishmania 4 8 4
on August 27, 2018 by guest
http://iai.asm.org/
Dow
nloaded from
major reveals a role for Toll-like receptor 4 in the control of parasite replication. J Leukoc Biol 4 8 5
76:48-57. 4 8 6
32. Liese, J., U. Schleicher, and C. Bogdan. 2008. The innate immune response against 4 8 7
Leishmania parasites. Immunobiology 213:377-387. 4 8 8
33. Liese, J., U. Schleicher, and C. Bogdan. 2007. TLR9 signaling is essential for the innate NK 4 8 9
cell response in murine cutaneous leishmaniasis. Eur J Immunol 37:3424-3434. 4 9 0
34. Martinez, F. O., S. Gordon, M. Locati, and A. Mantovani. 2006. Transcriptional profiling of 4 9 1
the human monocyte-to-macrophage differentiation and polarization: new molecules and 4 9 2
patterns of gene expression. J Immunol 177:7303-7311. 4 9 3
35. Medzhitov, R. 2007. Recognition of microorganisms and activation of the immune response. 4 9 4
Nature 449:819-826. 4 9 5
36. Miranda-Verastegui, C., G. Tulliano, T. W. Gyorkos, W. Calderon, E. Rahme, B. Ward, M. 4 9 6
Cruz, A. Llanos-Cuentas, and G. Matlashewski. 2009. First-line therapy for human 4 9 7
cutaneous leishmaniasis in Peru using the TLR7 agonist imiquimod in combination with 4 9 8
pentavalent antimony. PLoS Negl Trop Dis 3:e491. 4 9 9
37. Mosser, D. M., and A. Brittingham. 1997. Leishmania, macrophages and complement: a tale 5 0 0
of subversion and exploitation. Parasitology 115 Suppl:S9-23. 5 0 1
38. Mosser, D. M., and P. J. Edelson. 1984. Activation of the alternative complement pathway by 5 0 2
Leishmania promastigotes: parasite lysis and attachment to macrophages. J Immunol 5 0 3
132:1501-1505. 5 0 4
39. Mosser, D. M., and P. J. Edelson. 1985. The mouse macrophage receptor for C3bi (CR3) is 5 0 5
a major mechanism in the phagocytosis of Leishmania promastigotes. J Immunol 135:2785-5 0 6
2789. 5 0 7
on August 27, 2018 by guest
http://iai.asm.org/
Dow
nloaded from
40. Mosser, D. M., and J. P. Edwards. 2008. Exploring the full spectrum of macrophage 5 0 8
activation. Nat Rev Immunol 8:958-969. 5 0 9
41. Mosser, D. M., and L. A. Rosenthal. 1993. Leishmania-macrophage interactions: multiple 5 1 0
receptors, multiple ligands and diverse cellular responses. Semin Cell Biol 4:315-322. 5 1 1
42. Muraille, E., C. De Trez, M. Brait, P. De Baetselier, O. Leo, and Y. Carlier. 2003. 5 1 2
Genetically resistant mice lacking MyD88-adapter protein display a high susceptibility to 5 1 3
Leishmania major infection associated with a polarized Th2 response. J Immunol 170:4237-5 1 4
4241. 5 1 5
43. Murray, H. W., J. D. Berman, C. R. Davies, and N. G. Saravia. 2005. Advances in 5 1 6
leishmaniasis. Lancet 366:1561-1577. 5 1 7
44. Muskus, C., I. Segura, R. Oddone, S. J. Turco, D. A. Leiby, L. Toro, S. Robledo, and N. 5 1 8
G. Saravia. 1997. Carbohydrate and LPG expression in Leishmania viannia subgenus. J 5 1 9
Parasitol 83:671-678. 5 2 0
45. Pan, C., C. Kumar, S. Bohl, U. Klingmueller, and M. Mann. 2009. Comparative proteomic 5 2 1
phenotyping of cell lines and primary cells to assess preservation of cell type-specific 5 2 2
functions. Mol Cell Proteomics 8:443-450. 5 2 3
46. Pearson, R. D., J. L. Harcus, D. Roberts, and G. R. Donowitz. 1983. Differential survival of 5 2 4
Leishmania donovani amastigotes in human monocytes. J Immunol 131:1994-1999. 5 2 5
47. Pham, N. K., J. Mouriz, and P. E. Kima. 2005. Leishmania pifanoi amastigotes avoid 5 2 6
macrophage production of superoxide by inducing heme degradation. Infect Immun 73:8322-5 2 7
8333. 5 2 8
48. Prina, E., S. Z. Abdi, M. Lebastard, E. Perret, N. Winter, and J. C. Antoine. 2004. Dendritic 5 2 9
cells as host cells for the promastigote and amastigote stages of Leishmania amazonensis: 5 3 0
the role of opsonins in parasite uptake and dendritic cell maturation. J Cell Sci 117:315-325. 5 3 1
on August 27, 2018 by guest
http://iai.asm.org/
Dow
nloaded from
49. Qiao, H., M. V. Andrade, F. A. Lisboa, K. Morgan, and M. A. Beaven. 2006. FcepsilonR1 5 3 2
and toll-like receptors mediate synergistic signals to markedly augment production of 5 3 3
inflammatory cytokines in murine mast cells. Blood 107:610-618. 5 3 4
50. Ribeiro-de-Jesus, A., R. P. Almeida, H. Lessa, O. Bacellar, and E. M. Carvalho. 1998. 5 3 5
Cytokine profile and pathology in human leishmaniasis. Braz J Med Biol Res 31:143-148. 5 3 6
51. Rittirsch, D., M. A. Flierl, D. E. Day, B. A. Nadeau, F. S. Zetoune, J. V. Sarma, C. M. 5 3 7
Werner, G. A. Wanner, H. P. Simmen, M. S. Huber-Lang, and P. A. Ward. 2009. Cross-talk 5 3 8
between TLR4 and FcgammaReceptorIII (CD16) pathways. PLoS Pathog 5:e1000464. 5 3 9
52. Robledo, S., A. Wozencraft, A. Z. Valencia, and N. Saravia. 1994. Human monocyte 5 4 0
infection by Leishmania (Viannia) panamensis. Role of complement receptors and correlation 5 4 1
of susceptibility in vitro with clinical phenotype. J Immunol 152:1265-1276. 5 4 2
53. Rocha, F. J., U. Schleicher, J. Mattner, G. Alber, and C. Bogdan. 2007. Cytokines, 5 4 3
signaling pathways, and effector molecules required for the control of Leishmania (Viannia) 5 4 4
braziliensis in mice. Infect Immun 75:3823-3832. 5 4 5
54. Saravia, N. G., K. Weigle, I. Segura, S. H. Giannini, R. Pacheco, L. A. Labrada, and A. 5 4 6
Goncalves. 1990. Recurrent lesions in human Leishmania braziliensis infection--reactivation 5 4 7
or reinfection? Lancet 336:398-402. 5 4 8
55. Schleicher, U., J. Liese, I. Knippertz, C. Kurzmann, A. Hesse, A. Heit, J. A. Fischer, S. 5 4 9
Weiss, U. Kalinke, S. Kunz, and C. Bogdan. 2007. NK cell activation in visceral 5 5 0
leishmaniasis requires TLR9, myeloid DCs, and IL-12, but is independent of plasmacytoid 5 5 1
DCs. J Exp Med 204:893-906. 5 5 2
56. Shimazu, R., S. Akashi, H. Ogata, Y. Nagai, K. Fukudome, K. Miyake, and M. Kimoto. 5 5 3
1999. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 5 5 4
4. J Exp Med 189:1777-1782. 5 5 5
on August 27, 2018 by guest
http://iai.asm.org/
Dow
nloaded from
57. Soong, L. 2008. Modulation of dendritic cell function by Leishmania parasites. J Immunol 5 5 6
180:4355-4360. 5 5 7
58. Tabeta, K., K. Hoebe, E. M. Janssen, X. Du, P. Georgel, K. Crozat, S. Mudd, N. Mann, S. 5 5 8
Sovath, J. Goode, L. Shamel, A. A. Herskovits, D. A. Portnoy, M. Cooke, L. M. Tarantino, 5 5 9
T. Wiltshire, B. E. Steinberg, S. Grinstein, and B. Beutler. 2006. The Unc93b1 mutation 3d 5 6 0
disrupts exogenous antigen presentation and signaling via Toll-like receptors 3, 7 and 9. Nat 5 6 1
Immunol 7:156-164. 5 6 2
59. Takeda, K., T. Kaisho, and S. Akira. 2003. Toll-like receptors. Annu Rev Immunol 21:335-5 6 3
376. 5 6 4
60. Tuon, F. F., V. S. Amato, H. A. Bacha, T. Almusawi, M. I. Duarte, and V. Amato Neto. 5 6 5
2008. Toll-like receptors and leishmaniasis. Infect Immun 76:866-872. 5 6 6
61. Vargas-Inchaustegui, D. A., W. Tai, L. Xin, A. E. Hogg, D. B. Corry, and L. Soong. 2009. 5 6 7
Distinct roles for MyD88 and Toll-like receptor 2 during Leishmania braziliensis infection in 5 6 8
mice. Infect Immun 77:2948-2956. 5 6 9
62. Whitaker, S. M., M. Colmenares, K. G. Pestana, and D. McMahon-Pratt. 2008. Leishmania 5 7 0
pifanoi proteoglycolipid complex P8 induces macrophage cytokine production through Toll-like 5 7 1
receptor 4. Infect Immun 76:2149-2156. 5 7 2
63. Woelbing, F., S. L. Kostka, K. Moelle, Y. Belkaid, C. Sunderkoetter, S. Verbeek, A. 5 7 3
Waisman, A. P. Nigg, J. Knop, M. C. Udey, and E. von Stebut. 2006. Uptake of Leishmania 5 7 4
major by dendritic cells is mediated by Fcgamma receptors and facilitates acquisition of 5 7 5
protective immunity. J Exp Med 203:177-188. 5 7 6
5 7 7
Figure legends 5 7 8
5 7 9
on August 27, 2018 by guest
http://iai.asm.org/
Dow
nloaded from
FIGURE 1. L. panamensis infection induces TNF production at comparable level and kinetics 5 8 0
as specific TLR ligands. (A) Kinetics of TNFc"production in human primary macrophages exposed 5 8 1
to different parasite-to-cell ratios demonstrated maximum cytokine secretion 8 h post-infection. Data 5 8 2
are representative of cytokine production by macrophages of 10 individuals and are expressed as the 5 8 3
mean ‒ SEM. (B) Production of TNFc in human primary macrophages from 10 different donors was 5 8 4
measured by ELISA. Cells were stimulated with zymosan, LPS, Poly I:C, infected 8 h with 5 8 5
promastigotes 5:1 parasite-to-macrophage ratio or left untreated as a control. Data are expressed as 5 8 6
mean ± SD. *(p< 0.05), **(p< 0.01) 5 8 7
5 8 8
FIGURE 2. L. panamensis induces increased expression of TLR 1, 2, 3 and 4 in human 5 8 9
macrophages. Human macrophages were cultured without treatment, infected with L. panamensis 5 9 0
promastigotes at 5:1 parasite-to-macrophage ratio or stimulated with zymosan (TLR1), Pam2CSK4 5 9 1
(TLR2), Poly I:C (TLR3), LPS (TLR4) or CpG (TLR9). TLR expression was evaluated after 8 h of 5 9 2
exposure to ligands or promastigotes by flow cytometry. Upper panel: MFI of TLR expression from un-5 9 3
infected (empty triangle) and infected macrophages (filled circle) from 12 different individuals, P values 5 9 4
are indicated. Lower panel: Representative histograms of TLR expression of uninfected macrophages, 5 9 5
and macrophages exposed to specific TLR ligands, or L. panamensis promastigotes. Cells were gated 5 9 6
on the CD14+ population. 5 9 7
5 9 8
FIGURE 3. L. panamensis promastigotes and amastigotes induce TNF production in a dose-5 9 9
dependent manner and activate macrophages through TLR dependent signaling. (A) 6 0 0
TNFc"production by WT macrophages exposed to increasing parasite-to-cell ratios using opsonized 6 0 1
promastigotes or amastigotes, specific TLR ligands (shaded bars), or untreated. (B) MyD88/TRIF-/- 6 0 2
on August 27, 2018 by guest
http://iai.asm.org/
Dow
nloaded from
cells were infected at a 100:1 parasite-to-macrophage ratio. Data are representative of three 6 0 3
independent experiments and are expressed as the mean ‒ SEM. *(p< 0.05). 6 0 4
6 0 5
FIGURE 4. MyD88 or TRIF molecules are required for induction of TNF production during L. 6 0 6
panamensis infection. TNFc production by MyD88-/- (A) and TRIF-/- (B) macrophages co-cultured 6 0 7
with opsonized or non-opsonized L. panamensis promastigotes and amastigotes at 100:1 parasite-to-6 0 8
macrophage ratio, stimulated with specific TLR ligands, Sendai virus (shaded bars) and untreated. 6 0 9
Data are from three independent experiments and are expressed as the mean ‒ SEM. 6 1 0
6 1 1
FIGURE 5. Endolysosomal TLRs play a role in the induction of TNF production during L. 6 1 2
panamensis infection. TNFc production by UNC93b deficient macrophages co-cultured with L. 6 1 3
panamensis promastigotes or amastigotes at 100:1 parasite-to-macrophage ratio, stimulated with 6 1 4
specific intracellular TLR ligands and LPS (shaded bars), and untreated (medium). Data are from three 6 1 5
independent experiments and are expressed as the mean ‒ SEM.*(p< 0.05). 6 1 6
6 1 7
FIGURE 6. L. panamensis induces TNF production by macrophages through TLR4 but not 6 1 8
TLR2. TNFc production by (A) TLR2-/-, (B) TLR4-/- macrophage cell lines and (C) differentiated MD-2-/- 6 1 9
BMM (C57BL/6). BMMs were untreated (medium) or co-cultured with L. panamensis promastigotes 6 2 0
and amastigotes at 100:1 parasite-to-macrophage ratio, or stimulated with specific TLR ligands and 6 2 1
LPS alone or in combination with Eritoran (shaded bars). Figures summarize three independent 6 2 2
experiments and are expressed as the mean ‒ SEM. *(p< 0.05). 6 2 3
6 2 4
FIGURE 7. TLR4 mediates early macrophage leishmanicidal activity. (A) Parasite infection and 6 2 5
survival in WT (C57BL/6) and TLR4-/- macrophages infected with L. p-Luc promastigotes. Figure 6 2 6
on August 27, 2018 by guest
http://iai.asm.org/
Dow
nloaded from
shows the relative light units (RLU) of three independent experiments performed in duplicate. 6 2 7
**(p<0.01) vs WT cells. (B) Confocal microscopy images of WT and TLR4-/- mouse macrophages 6 2 8
infected with L. p-GFP promastigotes. Cell membranes were stained with CellMask red deep. Images 6 2 9
show parasites internalized after 30 min of infection. Images of entire slides (right side) show a 6 3 0
representative overview of WT and TLR4-/- macrophage infection. 6 3 1
6 3 2
FIGURE 8. Activation of primary bone marrow macrophages by L. panamensis is TLR4 6 3 3
dependent and signaling is preferentially mediated by MyD88. TNFc production by differentiated 6 3 4
(A) TLR4-/-, (B) MyD88-/-, (C) TRIF-/- and (D) MyD88/TRIF-/- (C57BL/6) BMMs untreated (medium), co-6 3 5
cultured with L. panamensis promastigotes at 100:1 parasite-to-macrophage ratio, stimulated with 6 3 6
specific TLR ligands and Sendai virus (shaded bars). Figures summarize data from three independent 6 3 7
experiments expressed as the mean ‒ SEM. *(p< 0.05). 6 3 8
on August 27, 2018 by guest
http://iai.asm.org/
Dow
nloaded from
FIGURE 1
25 min 4 h 8 h 24 h0
500
1000
1500
2000
2500
3000
5 par:cell1 par:cell
10 par:cell
*
*
Time post-exposition
TN
Fc
(p
g/m
l)
Medium Zymosan LPS Poly I:C L. panamensis10
100
1000
10000
100000**
TN
Fc
(p
g/m
l)
A
B
on August 27, 2018 by guest
http://iai.asm.org/
Dow
nloaded from
TLR1(p= 0.018)
0
25
50
75
100
MF
I
TLR2(p= 0.021)
0
50
100
150
200
TLR3(p= 0.007)
0
200
400
600
800
TLR4(p= 0.012)
0
50
100
150
200
TLR9(p= 0.30)
0
100
200
300
FIGURE 2
on August 27, 2018 by guest
http://iai.asm.org/
Dow
nloaded from
FIGURE 3
LPS (TLR
4)
LPS+ Erit
oran
Pam2C
SK4
(TLR
2)
CpG
(TLR
9)
Poly I:
C (T
LR3)
Sendai
Viru
s0
250
500
750
1000
1250
1500
Medium 50 100 200 25 50 100
promastigotes:cell
L. panamensisL. panamensis + Eritoran
amastigotes:cell
TN
Fc
(p
g/m
l)
LPS (TLR
4)
Pam2C
SK4
(TLR
2)
CpG
(TLR
9)
Poly I:
C (T
LR3)
Sendai
Viru
s0
200
400
600
800
1000
1200
1400
1600
1800
promastigotes amastigotes
WT
MediumMyD88/TRIF-/-
*
*
TN
Fc
(p
g/m
l)
A
B
on August 27, 2018 by guest
http://iai.asm.org/
Dow
nloaded from
FIGURE 4
LPS (TLR
4)
Pam2C
SK4
(TLR
2)
Poly I:
C (T
LR3)
Sendai
Viru
s0
200
400
600
800
1000
1200
1400
1600
1800
promastigotes amastigotes
WT
MyD88-/-Medium
ops non ops ops non ops
TN
Fc
(p
g/m
l)
Poly I:
C (T
LR3)
LPS (TLR
4)
Pam2C
SK4
(TLR
2)
Sendai
Viru
s0
200
400
600
800
1000
1200
1400
1600
1800
WTTRIF-/-Medium
promastigotes amastigotesops non ops ops non ops
TN
Fc
(p
g/m
l)
A
B
on August 27, 2018 by guest
http://iai.asm.org/
Dow
nloaded from
FIGURE 5
CpG
(TLR
9)
Poly I:
C (T
LR3)
LPS (TLR
4)0
200
400
600
800
1000
1200
1400
1600
1800
WTUNC93b mutantMedium
*
promastigotes amastigotesops non ops ops non ops
* **
TN
Fc
(p
g/m
l)
on August 27, 2018 by guest
http://iai.asm.org/
Dow
nloaded from
FIGURE 6
Pam2C
SK4
(TLR
2)
LPS (TLR
4)0
200
400
600
800
1000
1200
1400
1600
1800
TLR2-/-
WT
promastigotes amastigotes
Medium
ops non ops ops non ops
TN
Fc
(p
g/m
l)
LPS (TLR
4)
LPS+ Erit
oran
Pam2C
SK4
(TLR
2)0
200
400
600
800
1000
1200
1400
1600
1800
WT
MediumTLR4-/-
promastigotes amastigotesops non ops ops non ops
**
* *
TN
Fc
(p
g/m
l)
LPS (TLR
4)
LPS+ Erit
oran
Pam2C
SK4
(TLR
2)0
200
400
600
800
1000
1200L. panamensisMedium
L. panamensis + Eritoran
promastigotes amastigotes
MD-2-/-WT WTMD-2-/-
TN
Fc
(p
g/m
l)
A
B
C
on August 27, 2018 by guest
http://iai.asm.org/
Dow
nloaded from
4 16 24 480
50000
100000
150000
200000
250000
300000
350000WT
TLR4 -/-
**
hours
RL
U
FIGURE 7
A
B
Cell membrane L. panamensis-GFP Overlay
WT
TLR4-/-
on August 27, 2018 by guest
http://iai.asm.org/
Dow
nloaded from
FIGURE 8.
LPS (TLR
4)
Pam2C
SK4
(TLR
2)0
200
400
600
800
1000
1200Medium
opsonized non opsonized
TLR4 -/-
WT
*
*
TN
Fc
(p
g/m
l)
LPS (TLR
4)
Pam2C
SK4
(TLR
2)
Poly I:
C (T
LR3)
Sendai
viru
s0
200
400
600
800
1000
1200
opsonized non opsonized
MyD88/TRIF -/-
WT
Medium
*
*
TN
Fc
(p
g/m
l)
LPS (TLR
4)
Pam2C
SK4
(TLR
2)
Sendai
viru
s
Poly I:
C (T
LR3)
0
200
400
600
800
1000
1200
opsonized non opsonized
MyD88-/-
WT
Medium
*
*
TN
Fc
(p
g/m
l)
Poly I:
C (T
LR3)
LPS (TLR
4)
Pam2C
SK4
(TLR
2)
Sendai
viru
s0
200
400
600
800
1000
1200
1400
TRIF-/-
WT
Medium
opsonized non opsonized
TN
Fc
(p
g/m
l)
A
B
C
D
on August 27, 2018 by guest
http://iai.asm.org/
Dow
nloaded from